Abstract:Background 5q‐Spinal muscular atrophy (SMA) is now one of the 5% treatable rare diseases worldwide. As disease‐modifying therapies alter disease progression and patient phenotypes, paediatricians and consulting disciplines face new unknowns in their treatment decisions. Conclusions made from historical patient data sets are now mostly limited, and new approaches are needed to ensure our continued best standard‐of‐care practices for this exceptional patient group. Here, we present a data‐driven machine learning approach to a rare disease data set to predict spinal muscular atrophy (SMA)‐associated scoliosis. Methods We collected data from 84 genetically confirmed 5q‐SMA patients who have received novel SMA therapies. We performed expert domain knowledge‐directed feature engineering, correlation and predictive power score (PPS) analyses for feature selection. To test the predictive performance of the selected features, we trained a Random Forest Classifier and evaluated model performance using standard metrics. Results The SMA data set consisted of 1304 visits and over 360 variables. We performed feature engineering for variables related to 'interventions', 'devices', 'orthosis', 'ventilation', 'muscle contractures' and 'motor milestones'. Through correlation and PPS analysis paired with expert domain knowledge feature selection, we identified relevant features for scoliosis prediction in SMA that included disease progression markers: Hammersmith Functional Motor Scale Expanded 'HFMSE' (PPS = 0.27) and 6‐Minute Walk Test '6MWT' scores (PPS = 0.44), 'age' (PPS = 0.41) and 'weight' (PPS = 0.49), 'contractures' (PPS = 0.17), the use of 'assistive devices' (PPS = 0.39, 'ventilation' (PPS = 0.16) and the presence of 'gastric tubes' (PPS = 0.35) in SMA patients. These features were validated using expert domain knowledge and used to train a Random Forest Classifier with an observed accuracy of 0.82 and an average receiver operating characteristic (ROC) area of 0.87. Conclusion The introduction of disease‐modifying SMA therapies, followed by the implementation of SMA in newborn screenings, has presented physicians with never‐seen patients. We used feature engineering tools to overcome one of the main challenges when using data‐driven approaches in rare disease data sets. Through predictive modelling of this data, we defined disease progression markers, which are easily assessed during patient visits and can help anticipate scoliosis onset. This highlights the importance of progressive features in the drug‐induced revolution of this rare disease and further supports the ongoing efforts to update the SMA classification. We advocate for the consistent documentation of relevant progression markers, which will serve as a basis for data‐driven models that physicians can use to update their best standard‐of‐care practices.

An interpretable data-driven prediction model to anticipate scoliosis in spinal muscular atrophy in the era of (gene-) therapies

Feature Engineering for the Prediction of Scoliosis in 5q‐Spinal Muscular Atrophy

From data to discovery: AI-guided analysis of disease-relevant molecules in spinal muscular atrophy (SMA)

Detecting missed diagnoses of spinal muscular atrophy in genome, exome, and panel sequencing datasets

Scoliosis Development in Spinal Muscular Atrophy: The Influences of Genetic Severity, Functional Level, and Disease-Modifying Treatments

Spinal Muscular Atrophy Scoliosis in the Era of Background Therapies—A Review of the Literature

Visual Prediction of the Progression of Spinocerebellar Ataxia Type 3 Based on Machine Learning

3D Morphology Prediction of Progressive Spinal Deformities from Probabilistic Modeling of Discriminant Manifolds

Biomarkers in 5q-associated spinal muscular atrophy-a narrative review

Machine learning-enhanced electrical impedance myography to diagnose and track spinal muscular atrophy progression

Biomarkers and the Development of a Personalized Medicine Approach in Spinal Muscular Atrophy

Evaluating the clinical efficacy of a long-read sequencing-based approach for carrier screening of spinal muscular atrophy

Diagnosis of Challenging Spinal Muscular Atrophy Cases with Long-Read Sequencing

Comprehensive profile and natural history of pediatric patients with spinal muscular atrophy: A large retrospective study from China

Accounting for Biomechanical Measures from Musculoskeletal Simulation of Upright Posture Does Not Enhance the Prediction of Curve Progression in Adolescent Idiopathic Scoliosis

Correlative Assessment of Machine Learning-Based Cobb Angle Measurements and Human-Based Measurements in Adolescent Idiopathic and Congenital Scoliosis

Spinal Muscular Atrophy Modeling and Treatment Advances by Induced Pluripotent Stem Cells Studies

Real-time prediction of postoperative spinal shape with machine learning models trained on finite element biomechanical simulations

Identification of Biochemical Determinants for Diagnosis and Prediction of Severity in 5q Spinal Muscular Atrophy Using 1H-Nuclear Magnetic Resonance Metabolic Profiling in Patient-Derived Biofluids

Machine learning algorithms for predicting Cobb angle beyond 25 degrees in female adolescent idiopathic scoliosis patients

In Search of Spinal Muscular Atrophy Disease Modifiers